Is AXIM Biotechnologies, Inc. (AXIM) a Buy, Sell, or Hold?
OTC : AXIM
AXIM Biotechnologies, Inc.
$0.005 USD
$0.0 (66.67%)
- Volume
- 1.05M
- Average Volume
- 248.21K
- Market Capitalization
- $1.7M
- P/E Ratio
- -3.33
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.03
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.00
Company Overview
OTC
Catalina Valencia
Biotechnology
Healthcare
AXIM
7
US
USD
Liquidity Metrics
-0.70
0.00
0.00
0.00
0.00
Sales & Valuation
-$
9.20
-0.15
40.54
0.00
Profitability
-$0.0031
-$1.04M
-267.24%
-267.24%
4.53%
-14.66%
P/E Metrics
-3.33
-0.02
-0.02
Analyst Price Target & Rating
1/5
0 Analysts
%
Financial Health Scores
-34.53
4/9
-$6.17M
$3.37M
$14.42M
-$728.66K
Key Metrics (TTM)
$8.81M
47.60
-28.98
0.00
4.53%
44.37%
-48.40%
4.11%
-1573 days
Company Executives
| Name | Title |
|---|---|
| Kurt Phinney | Chief Operating Officer |
| Catalina Valencia | Chief Executive Officer, President & Director |
| Sergei A. Svarovsky | Chief Scientific Officer |
| Jeffrey A. Busby | Head of Global Sales |
| Robert T. Malasek | Chief Financial Officer & Secretary |
| Douglas Lake | Chief Clinical Officer of Sapphire Biotech, Inc. |
| Joseph Tauber | Chief Medical Officer & Chairman of the Medical Advisory Board |
| Maria J. Gonzalez Moa | Vice President of Product Development - Sapphire Biotech, Inc. |
Poll Results
No votes yet today — be the first to share your view!
About AXIM Biotechnologies, Inc. (OTC:AXIM) Stock
AXIM Biotechnologies, Inc. specializes in the creation and distribution of advanced diagnostic solutions for healthcare, focusing on critical areas such as SARS-CoV-2 (COVID-19), ocular health, and cancer treatment. The company is currently developing rapid diagnostic assays that quantify functional neutralizing antibodies, which are essential for preventing the SARS-CoV-2 virus from attaching to human cells. Additionally, it offers serological diagnostic tests designed to detect neutralizing antibodies, thereby assessing the body's adaptive immune response to the virus, and is developing tests to identify inflammation biomarkers for the effective management of COVID-19 patients. For eye health, AXIM is pioneering quick, quantitative tear tests to measure Matrix metalloproteinase-9, an inf ... lammatory marker associated with dry eye disease. In its oncology pipeline, the firm is advancing SBI-183, an anti-metastatic compound engineered to inhibit tumor cell growth and block the spread of cancer, as well as SPX-1009, another anti-metastatic therapy aimed at determining the levels of quiescin sulfhydryl oxidase I. Established in 2010, the company was formerly known as Axim International Inc. before officially changing its name to AXIM Biotechnologies, Inc. in July 2014, and it is headquartered in San Diego, California.
Frequently Asked Questions
-
What is the current AXIM Biotechnologies, Inc. (AXIM) stock price?
-
AXIM Biotechnologies, Inc.(OTC:AXIM) stock price is $0.005 in the last trading session. During the trading session, AXIM stock reached the peak price of $0.029 while $0.002 was the lowest point it dropped to. The percentage change in AXIM stock occurred in the recent session was 66.67% while the dollar amount for the price change in AXIM stock was $0.0.
-
AXIM's industry and sector of operation?
-
The OTC listed AXIM is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of AXIM?
-
Kurt Phinney | Chief Operating Officer
Catalina Valencia | Chief Executive Officer, President & Director
Sergei A. Svarovsky | Chief Scientific Officer
Jeffrey A. Busby | Head of Global Sales
Robert T. Malasek | Chief Financial Officer & Secretary -
How many employees does AXIM have?
-
Number of AXIM employees currently stands at 7. AXIM operates from 6191 Cornerstone Court, East, San Diego, CA 92121, US.
-
Link for AXIM official website?
-
Official Website of AXIM is: https://www.aximbiotech.com
-
How do I contact AXIM?
-
AXIM could be contacted at phone #858 923 4422 and can also be accessed through its website. AXIM operates from 6191 Cornerstone Court, East, San Diego, CA 92121, US.
-
How many shares of AXIM are traded daily?
-
The average number of AXIM shares traded daily for last 3 months was 248.21K.
-
What is the market cap of AXIM currently?
-
The market value of AXIM currently stands at $1.7M with its latest stock price at $0.005